BeOne Medicines
ONC
#694
Rank
โ‚น3.352 T
Marketcap
โ‚น29,188
Share price
-1.81%
Change (1 day)
49.40%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: โ‚น3.352 Trillion

As of April 2026 BeOne Medicines has a market cap of โ‚น3.352 Trillion. This makes BeOne Medicines the world's 694th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น3.352 T8.03%
2025โ‚น3.103 T76.63%
2024โ‚น1.756 T7.06%
2023โ‚น1.641 T-22.02%
2022โ‚น2.104 T1.74%
2021โ‚น2.068 T19.5%
2020โ‚น1.731 T137.57%
2019โ‚น728.63 B24.68%
2018โ‚น584.38 B105.65%
2017โ‚น284.17 B247.13%
2016โ‚น81.86 B

End of Day market cap according to different sources

On Apr 21st, 2026 the market cap of BeOne Medicines was reported to be:

โ‚น3.460 Trillion
by Nasdaq info icon info icon
โ‚น3.352 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
โ‚น87.53 B-97.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น1.95 B-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA